Table 2.
Year(s) | All Patients | Total Examined Patients | Rate of Total Examined Patients | Screening Exams (Retinopathy−) | Rate of Screening Exams (Retinopathy−) * |
---|---|---|---|---|---|
3/2017–3/2018 | 696 | 189 | 27.2% | 94 | 16.4% |
3/2018–3/2019 | 699 | 199 | 28.4% | 99 | 17.4% |
3/2019–3/2020 | 691 | 234 | 33.9% | 122 | 22.1% |
3/2020–9/2020 | 512 | 37 | 7.2% | 13 | 2.8% |
9/2020–3/2021 | 493 | 99 | 20.0% | 44 | 10.6% |
All Patients: Total SCD patients seen by a physician during the timeframe. Total Examined Patients: SCD patients who had an eye exam during the timeframe. Rate of Total Examined Patients: Rate of SCD patients with an eye exam, Total Examined Patients/All Patients. Screening exams: Number of SCD patients without a previous diagnosis of retinopathy (Retinopathy−) who had a (screening) eye exam during the timeframe. Rate of screening exams: a rate of screened patients among SCD patients without a previous diagnosis of retinopathy (Retinopathy−). * Rate of screening exams was calculated as follows: (Retinopathy− with screening exams)/(All Patients − (retinopathic patients)) = (Retinopathy− with screening exams)/(All Patients − (SCD patients not seen by a Montefiore ophthalmologist but with retinopathy noted in EMR + (Retinopathy+))).